This was the stock's fourth consecutive day of losses.

Edward Lifesciences remains a "Hold" as it trades close to its intrinsic value, despite improved fundamentals and solid third ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...

In a report released yesterday, Lee Hambright from Bernstein maintained a Hold rating on Edwards Lifesciences (EW – Research Report). The ...

Edwards Lifesciences EW, following the sell-off of the Critical Care wing, looks forward to developing the most comprehensive structural heart portfolio. In TMTT, the robust adoption of the ...

Edwards Lifesciences Corporation (EW), a global leader in patient-focused medical innovations, was founded in 1958 and is headquartered in Irvine, California. With a market cap of $42.2 billion ...

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Evercore ISI raised the firm’s price target on Edwards Lifesciences (EW) to $75 from $69 and keeps an In Line rating on the shares. In the ...

Edwards Lifesciences Corp (EW) stock saw a decline, ending the day at $75.65 which represents a decrease of $-0.27 or -0.36% from the prior close of $75.92. The stock opened at $75.29 and touched a ...

Shares of Edwards Lifesciences Corp. EW shed 0.88% to $70.90 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.61% to ...

Edwards Lifesciences is currently trading 25.6% below its 52-week high of $96.12, reached on Mar. 28.Shares of Edwards Lifesciences gained 7.1% over the three months, underperforming the broader S ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative products and technologies for structural heart disease and critical care ...